The Latest Cardiac and Vascular News
PEWAUKEE, Wis. and MEMPHIS, Tenn. , March 10, 2022 /PRNewswire/ — Lohman Technologies, a leader in home ECG monitoring solutions, released the findings from a 90-day pilot study at a Memphis, TN clinic. The goal of the pilot was to empower patients to collect daily ECG readings and have them sent directly to their primary care provider. The […]
3D Vector ECG Collection Device Slated for FDA 510k Submission in the Fourth Quarter of 2022 SANTA CLARA, Calif.–(BUSINESS WIRE)–HeartBeam, Inc. (NASDAQ: BEAT), a developmental stage digital healthcare company with a proprietary ECG telemedicine technology for heart attack detection, today announced it has signed a professional services agreement (the “Agreement”) with […]
March 9, 2022 As an initial remote monitoring diagnostic approach, Philips BioTel Heart MCOT detected 4.6 times more patients with atrial fibrillation compared to implantable loop recorder alone Almost eight times lower costs were achieved with improved detection rates and reduction of secondary stroke risk Remote cardiac monitoring via the MCOT […]
AI heart and lung disease screening solution top-ranked in the medical devices category, joins the likes of Canva, Microsoft, SpaceX, and more OAKLAND, Calif., March 8, 2022 /PRNewswire/ — Eko, a digital health company advancing heart and lung disease detection, has been named to Fast Company‘s annual list of the World’s Most Innovative Companies for 2022 in […]
The world’s first cellular-connected pulse oximeter facilitates remote monitoring for 67 million patients with chronic diseases. TAMPA, Fla., March 3, 2022 /PRNewswire/ — Smart Meter, the leader in cellular-enabled remote patient monitoring (RPM) data and devices, announces the release of the iPulseOxTM, the world’s first cellular-connected pulse oximeter, furthering the transformation of remote […]
ATHENS, Ga., March 3, 2022 /PRNewswire/ — Athena Bioscience, LLC announced plans for the commercial launch of Nexiclon XR, the only once-daily clonidine extended-release tablets indicated for treatment of hypertension.1 Athena acquired exclusive rights to commercialize the product from Tris Pharma, Inc. in February 2021. The launch is set for April 2022 in all 50 U.S. […]
Business Associate Agreement and Clinical Trial Agreement with Additional Planned Studies and Commercial and Scientific Collaboration SANTA CLARA, Calif.–(BUSINESS WIRE)–HeartBeam, Inc. (NASDAQ: BEAT), a developmental stage digital healthcare company with a proprietary ECG telemedicine technology for heart attack detection, today announced it has signed a Business Associate Agreement (BAA) and Clinical […]
Additional clinical research shows bradyarrhythmias can be detected with 14-day cardiac monitoring through Zio XT before and after TAVR SAN FRANCISCO, Feb. 28, 2022 (GLOBE NEWSWIRE) — iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital healthcare solutions company focused on the advancement of cardiac care, announced that the results of the KP-Rhythm2 study, titled […]
MARLBOROUGH, Mass., Feb. 28, 2022 /PRNewswire/ — Boston Scientific Corporation (NYSE: BSX) today announced positive results from a new analysis assessing real-world outcomes with the WATCHMAN FLX™ Left Atrial Appendage Closure (LAAC) Device. Presented during a late-breaking trial session at the Cardiovascular Research Technologies (CRT) 2022 meeting, the SURPASS analysis included data from more […]
Sweden’s Dental and Pharmaceutical Benefits Agency, TLV evaluated the combination of the KardiaMobile® and KardiaPro personal electrocardiogram (ECG) and software compared to the current standard of care, Holter ECG The health economic assessment found a higher degree of atrial fibrillation (AF) detection and resource-saving with KardiaMobile compared to Holter ECG 24 hours1 KardiaMobile […]
